Cargando…
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
Epstein-Barr virus (EBV) is associated with a range of epithelial and B cell malignancies as well as autoimmune disorders, for which there are still no specific treatments or effective vaccines. Here, we isolate EBV gH/gL-specific antibodies from an EBV-infected individual. One antibody, 1D8, effici...
Autores principales: | Zhu, Qian-Ying, Shan, Sisi, Yu, Jinfang, Peng, Si-Ying, Sun, Cong, Zuo, Yanan, Zhong, Lan-Yi, Yan, Shu-Mei, Zhang, Xiao, Yang, Ziqing, Peng, Yong-Jian, Shi, Xuanling, Cao, Su-Mei, Wang, Xinquan, Zeng, Mu-Sheng, Zhang, Linqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595662/ https://www.ncbi.nlm.nih.gov/pubmed/34785638 http://dx.doi.org/10.1038/s41467-021-26912-6 |
Ejemplares similares
-
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021) -
Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Zhu, Qian-Ying, et al.
Publicado: (2020) -
Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016) -
Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022) -
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
por: Shan, Sisi, et al.
Publicado: (2022)